Literature DB >> 16401279

MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.

Dongfeng Wu1, Gary L Rosner, Lyle Broemeling.   

Abstract

This article extends previous probability models for periodic breast cancer screening examinations. The specific aim is to provide statistical inference for age dependence of sensitivity and the transition probability from the disease free to the preclinical state. The setting is a periodic screening program in which a cohort of initially asymptomatic women undergo a sequence of breast cancer screening exams. We use age as a covariate in the estimation of screening sensitivity and the transition probability simultaneously, both from a frequentist point of view and within a Bayesian framework. We apply our method to the Health Insurance Plan of Greater New York study of female breast cancer and give age-dependent sensitivity and transition probability density estimates. The inferential methodology we develop is also applicable when analyzing studies of modalities for early detection of other types of progressive chronic diseases.

Entities:  

Mesh:

Year:  2005        PMID: 16401279      PMCID: PMC1540406          DOI: 10.1111/j.1541-0420.2005.00361.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Testing the independence of two diagnostic tests.

Authors:  Y Shen; D Wu; M Zelen
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Benefits of screening for breast cancer: application of a probabilistic model to a breast cancer detection project.

Authors:  N Dubin
Journal:  J Chronic Dis       Date:  1979

3.  Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group.

Authors:  H Straatman; P G Peer; A L Verbeek
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

4.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

5.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes.

Authors:  N E Day; S D Walter
Journal:  Biometrics       Date:  1984-03       Impact factor: 2.571

6.  Effect of age, breast density, and family history on the sensitivity of first screening mammography.

Authors:  K Kerlikowske; D Grady; J Barclay; E A Sickles; V Ernster
Journal:  JAMA       Date:  1996-07-03       Impact factor: 56.272

7.  Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening.

Authors:  J S Spratt; R A Greenberg; L S Heuser
Journal:  Cancer Res       Date:  1986-02       Impact factor: 12.701

8.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

Authors:  A B Miller; C J Baines; T To; C Wall
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

9.  Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.

Authors:  A B Miller; C J Baines; T To; C Wall
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

10.  Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening.

Authors:  Stuart G Baker; Diane Erwin; Barnett S Kramer; Philip C Prorok
Journal:  BMC Med Res Methodol       Date:  2003-03-06       Impact factor: 4.615

View more
  18 in total

1.  Sojourn time and lead time projection in lung cancer screening.

Authors:  Dongfeng Wu; Diane Erwin; Gary L Rosner
Journal:  Lung Cancer       Date:  2010-11-13       Impact factor: 5.705

2.  Simulation Procedure in Periodic Cancer Screening Trials.

Authors:  Dongfeng Wu; Xiaoqin Wu; Ioana Banicescu; Ricolindo L Cariño
Journal:  J Mod Appl Stat Methods       Date:  2005-11

3.  A limited Review of Over Diagnosis Methods and Long Term Effects in Breast Cancer Screening.

Authors:  Dongfeng Wu; Adriana Pérez
Journal:  Oncol Rev       Date:  2011-09-01

4.  Estimating key parameters in periodic breast cancer screening-application to the Canadian National Breast Screening Study data.

Authors:  Yinlu Chen; Guy Brock; Dongfeng Wu
Journal:  Cancer Epidemiol       Date:  2010-08       Impact factor: 2.984

5.  A Bayesian model for estimating multi-state disease progression.

Authors:  Shiwen Shen; Simon X Han; Panayiotis Petousis; Robert E Weiss; Frank Meng; Alex A T Bui; William Hsu
Journal:  Comput Biol Med       Date:  2016-12-22       Impact factor: 4.589

6.  Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial.

Authors:  Ruiqi Liu; Adriana Pérez; Dongfeng Wu
Journal:  J Healthc Inform Res       Date:  2018-06-12

7.  Bayesian inference for the lead time in periodic cancer screening.

Authors:  Dongfeng Wu; Gary L Rosner; Lyle D Broemeling
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

8.  Estimating key parameters in FOBT screening for colorectal cancer.

Authors:  Dongfeng Wu; Diane Erwin; Gary L Rosner
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

9.  A projection of benefits due to fecal occult blood test for colorectal cancer.

Authors:  Dongfeng Wu; Diane Erwin; Gary L Rosner
Journal:  Cancer Epidemiol       Date:  2009-09-04       Impact factor: 2.984

10.  A Bayesian nonlinear mixed-effects disease progression model.

Authors:  Seongho Kim; Hyejeong Jang; Dongfeng Wu; Judith Abrams
Journal:  J Biom Biostat       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.